Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Bladder Cancer

Free Subscription 13.02.2023 1 Acta Med Port 1 Aging Cancer 1 Anal Biochem 1 Anticancer Drugs 3 Asian J Surg 2 BJU Int 1 Br J Cancer 1 Cancer Commun (Lond) 1 Cancer Invest 1 Cardiovasc Intervent Radiol 1 Chem Biol Drug Des 1 Clin Chem 1 Cytopathology 1 Diagn Pathol 1 Eur Urol 1 Eur Urol Focus 1 Front Oncol 3 Gan To Kagaku Ryoho 1 Int J Hyperthermia 1 Int J Med Inform 1 J Comp Pathol 2 J Endourol 1 J Environ Pathol Toxicol Oncol 1 J Exp Clin Cancer Res 1 J Immunother 1 J Int Med Res 1 J Urol 1 Mol Cancer 1 Mol Clin Oncol 1 Nanomedicine 1 Pharmacoecon Open 3 PLoS One 1 Sci Rep 1 South Asian J Cancer

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Med Port

1. QUARESMA V, Marconi L, Jarimba R, Lima J, et al
   Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma at a Tertiary Referral Center in Portugal.
   Acta Med Port. 2023;36:145-146.
   PubMed        
   
   

   
   Aging Cancer

2. KESSLER ER, Schmiege SJ, Eguchi M, Singh S, et al
   Patterns of treatment in older patients with newly diagnosed advanced bladder cancer: A SEER dataset analysis.
   Aging Cancer. 2022;3:105-115.
   PubMed         Abstract available
   
   

   
   Anal Biochem

3. TABAEI S, Haghshenas MR, Webster TJ, Ghaderi A, et al
   Proteomic strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources.
   Anal Biochem. 2023 Feb 2:115074. doi: 10.1016/j.ab.2023.115074.
   PubMed         Abstract available
   
   

   
   Anticancer Drugs

4. QU F, Yan X, Yu W
   Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review.
   Anticancer Drugs. 2023;34:317-324.
   PubMed         Abstract available
   
   

   
   Asian J Surg

5. JIA K, Wang Y, Yang B, Wang H, et al
   Revisit the rare clinical cases of upper urinary tract metastases from gastrointestinal tumors.
   Asian J Surg. 2023;46:1103-1104.
   PubMed        
   
   
6. CHAO CW, Chung SD, Au CF
   Primary bladder amyloidosis mimicking bladder malignancy: A case report.
   Asian J Surg. 2023;46:1033-1035.
   PubMed        
   
   
7. CHENG TY, Tang TY, Hsu JM, Lin TF, et al
   Multifocal Xanthogranulomatous cystitis mimicking bladder malignancy: A case report and literature review.
   Asian J Surg. 2023;46:969-970.
   PubMed        
   
   

   
   BJU Int

8. MIGNOT F, Fabiano E, Xylinas E, Alati A, et al
   Clinical outcomes of adapted hypofractionated radiotherapy for bladder cancer in elderly patients.
   BJU Int. 2023 Feb 6. doi: 10.1111/bju.15983.
   PubMed         Abstract available
   
   
9. CLAPS F, van de Kamp MW, Mayr R, Bostrom PJ, et al
   Prognostic impact of variant histologies in urothelial bladder cancer treated by radical cystectomy.
   BJU Int. 2023 Feb 6. doi: 10.1111/bju.15984.
   PubMed         Abstract available
   
   

   
   Br J Cancer

10. XU L, Zhong W, Li C, Hong P, et al
    The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study).
    Br J Cancer. 2023;128:310-320.
    PubMed         Abstract available
    
    

    
    Cancer Commun (Lond)

11. WANG X, Zhang S, Jin D, Luo J, et al
    mu-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial.
    Cancer Commun (Lond). 2023 Feb 5. doi: 10.1002/cac2.12408.
    PubMed         Abstract available
    
    

    
    Cancer Invest

12. TU Y, Mao Z
    Identification and validation of molecular subtype and prognostic signature for bladder cancer based on neutrophil extracellular traps.
    Cancer Invest. 2023 Feb 10:1-12. doi: 10.1080/07357907.2023.2179063.
    PubMed         Abstract available
    
    

    
    Cardiovasc Intervent Radiol

13. DE KERVILER E, de Margerie-Mellon C, Dumont C, Pachev A, et al
    Salvage Percutaneous Cryoablation for Bleeding Upper Tract Urothelial Carcinoma.
    Cardiovasc Intervent Radiol. 2023;46:255-258.
    PubMed         Abstract available
    
    

    
    Chem Biol Drug Des

14. YIN L, Ying L, Guo R, Hao M, et al
    Ligustilide Induces Apoptosis and Reduces Proliferation in Human Bladder Cancer Cells by NFkappaB1 and Mitochondria Pathway.
    Chem Biol Drug Des. 2023 Feb 8. doi: 10.1111/cbdd.14207.
    PubMed         Abstract available
    
    

    
    Clin Chem

15. PAPADIMITRIOU MA, Levis P, Kotronopoulos G, Stravodimos K, et al
    Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome.
    Clin Chem. 2023 Feb 4:hvac218. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cytopathology

16. TANAKA S, Naritomi M, Monobe Y, Ariyasu S, et al
    The inclusion of nuclear area improves the Paris system for reporting urinary cytology.
    Cytopathology. 2023;34:106-112.
    PubMed         Abstract available
    
    

    
    Diagn Pathol

17. HELAL DS, Darwish SA, Awad RA, Ali DA, et al
    Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival.
    Diagn Pathol. 2023;18:11.
    PubMed         Abstract available
    
    

    
    Eur Urol

18. SUDERMAN J, St-Laurent MP, Black PC
    Re: IL-15 Superagonist NAI in BCG-Unresponsive Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2023 Feb 1:S0302-2838(23)00016-7. doi: 10.1016/j.eururo.2023.
    PubMed        
    
    

    
    Eur Urol Focus

19. TISSOT G, Xylinas E
    Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Chemoradiotherapy Versus Chemoradiotherapy Alone in Muscle-invasive Bladder Cancer: The MK-3475-992/KEYNOTE-992 Trial.
    Eur Urol Focus. 2023 Feb 1:S2405-4569(22)00295-4. doi: 10.1016/j.euf.2022.
    PubMed         Abstract available
    
    

    
    Front Oncol

20. CHEN Z, Chen D, Song Z, Lv Y, et al
    Mapping the tumor microenvironment in bladder cancer and exploring the prognostic genes by single-cell RNA sequencing.
    Front Oncol. 2023;12:1105026.
    PubMed         Abstract available
    
    

    
    Gan To Kagaku Ryoho

21. KUSAFUKA H, Ikeshima R, Kawai K, Hiraki M, et al
    [A Case of Laparoscopic Surgery for Sigmoid Colon Cancer after Cystectomy and Ileal Conduit Construction].
    Gan To Kagaku Ryoho. 2022;49:1870-1872.
    PubMed         Abstract available
    
    
22. IZUTANI Y, Nakata K, Takayama H, Miyake Y, et al
    [Case of Robot-Assisted Low Anterior Resection with Total Cystectomy for Rectal Cancer Invading the Urinary Bladder/Prostate in Collaboration with Urologists].
    Gan To Kagaku Ryoho. 2022;49:1565-1567.
    PubMed         Abstract available
    
    
23. NAKASE T, Hata T, Ikeshima R, Kawai K, et al
    [A Case of Robotic-Assisted Surgery for Simultaneous Triple Cancer of Rectum, Bladder, and Prostate].
    Gan To Kagaku Ryoho. 2022;49:1676-1677.
    PubMed         Abstract available
    
    

    
    Int J Hyperthermia

24. BRUMMELHUIS ISG, Crezee J, Witjes JA
    Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer.
    Int J Hyperthermia. 2023;40:2157498.
    PubMed         Abstract available
    
    

    
    Int J Med Inform

25. ZHANG Q, Liang Y, Zhang Y, Tao Z, et al
    A comparative study of attention mechanism based deep learning methods for bladder tumor segmentation.
    Int J Med Inform. 2023;171:104984.
    PubMed         Abstract available
    
    

    
    J Comp Pathol

26. HETTERICH J, Schmidt V, Herth M, Merhof K, et al
    Urothelial carcinoma in a Russian tortoise (Testudohorsfieldii).
    J Comp Pathol. 2023;200:18-22.
    PubMed         Abstract available
    
    

    
    J Endourol

27. KOMAI Y, Nakajima K, Saito K, Tomioka Y, et al
    Development of a New Two-Arm Transurethral Surgical System for En Bloc Resection of Bladder Tumor: A Preclinical Study.
    J Endourol. 2023;37:165-170.
    PubMed         Abstract available
    
    
28. HUANG YP, Huang EY, Chung HJ, Tai MC, et al
    Is Robotic Superior to Laparoscopic Approach for Radical Nephroureterectomy with Bladder Cuff Excision in Treating Upper Urinary Tract Urothelial Carcinoma?
    J Endourol. 2023;37:139-146.
    PubMed         Abstract available
    
    

    
    J Environ Pathol Toxicol Oncol

29. BUYUCEK S, Coskun SK, Onal B, Gamsizkan M, et al
    Receptor Tyrosine Kinase Pathway and Infiltrating Urothelial Carcinoma.
    J Environ Pathol Toxicol Oncol. 2023;42:65-77.
    PubMed         Abstract available
    
    

    
    J Exp Clin Cancer Res

30. LV J, Li K, Yu H, Han J, et al
    HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.
    J Exp Clin Cancer Res. 2023;42:41.
    PubMed         Abstract available
    
    

    
    J Immunother

31. DENG R, Zhang H, Li Y, Shi Y, et al
    Effect of Antacid Use on Immune Checkpoint Inhibitors in Advanced Solid Cancer Patients: A Systematic Review and Meta-analysis.
    J Immunother. 2023;46:43-55.
    PubMed         Abstract available
    
    

    
    J Int Med Res

32. AL-MAGHRABI JA, Khabaz MN
    Clinical significance of galectin-3 expression in urinary bladder carcinoma.
    J Int Med Res. 2023;51:3000605231153323.
    PubMed         Abstract available
    
    

    
    J Urol

33. CASTANEDA PR, Ahdoot M, Rosser CJ
    Re: Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomyis Prognostic but Not Therapeutic.
    J Urol. 2023 Feb 8:101097JU0000000000003362. doi: 10.1097/JU.0000000000003362.
    PubMed        
    
    

    
    Mol Cancer

34. YANG K, Hu H, Wu J, Wang H, et al
    Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
    Mol Cancer. 2023;22:25.
    PubMed         Abstract available
    
    

    
    Mol Clin Oncol

35. TOMINAGA Y, Fujii M, Sadahira T, Katayama S, et al
    Bladder tuberculosis with ureteral strictures after bacillus Calmette‑Guerin therapy for urinary bladder cancer: A case report.
    Mol Clin Oncol. 2022;18:7.
    PubMed         Abstract available
    
    

    
    Nanomedicine

36. REN S, Dai R, Zheng Z, Liu Q, et al
    A novel bidirectional perfusion-like administered system for NIR-II fluorescence imaging precision diagnosis of bladder cancer.
    Nanomedicine. 2023;49:102661.
    PubMed         Abstract available
    
    

    
    Pharmacoecon Open

37. COOPER OAE, Ghatnekar O, Piglowska N, Smith CA, et al
    Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC).
    Pharmacoecon Open. 2023 Feb 3. doi: 10.1007/s41669-023-00392.
    PubMed         Abstract available
    
    

    
    PLoS One

38. LIEDBERG F, Hagberg O, Haggstrom C, Aljabery F, et al
    Preoperative upper tract invasive diagnostic modalities are associated with intravesical recurrence following surgery for upper tract urothelial carcinoma: A population-based study.
    PLoS One. 2023;18:e0281304.
    PubMed         Abstract available
    
    
39. AHRENFELDT J, Christensen DS, Ostergaard AB, Kisistok J, et al
    The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy.
    PLoS One. 2023;18:e0281375.
    PubMed         Abstract available
    
    
40. FUJITA N, Hatakeyama S, Okita K, Momota M, et al
    Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.
    PLoS One. 2023;18:e0275921.
    PubMed         Abstract available
    
    

    
    Sci Rep

41. NI W, Yi L, Dong X, Cao M, et al
    PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
    Sci Rep. 2023;13:2051.
    PubMed         Abstract available
    
    

    
    South Asian J Cancer

42. MITTAL S, Malik K, Raja A
    Nonbilharzial Squamous Cell Bladder Cancer: An Indian Experience.
    South Asian J Cancer. 2022;11:322-325.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: